Ann: Acrux generic strategy and Axiron patent litigation update-ACR.AX, page-7

  1. 7,727 Posts.
    lightbulb Created with Sketch. 769
    shouldn't come as a surprise - doesn't surprise me BUT:
    1) comment that any lawsuit will not "materially" impact the company - would love to know how they define "materially";
    2) love the way they introduced the "potential" pipeline before hitting us with the litigation issue - gosh how silly are we to fall for the one-two hit;
    3) potential development pipeline late calendar year 2017 - hmmm
    4) if litigation lost then depending on how long in courts and whether competing products are able to sell whilst litigation on - could have a large impact on sales;
    5) always the issue with this "one trick pony". competitors - and what would explain the rather lacklustre approach to R&D in the past few years - too much resting on ones laurels maybe??
    6) surprised that the opportunity was not taken to inform us on the ins-outs of the Helix matter
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.7¢
Change
-0.001(5.56%)
Mkt cap ! $6.931M
Open High Low Value Volume
1.8¢ 1.9¢ 1.7¢ $8.809K 495.6K

Buyers (Bids)

No. Vol. Price($)
5 266679 1.7¢
 

Sellers (Offers)

Price($) Vol. No.
1.8¢ 252359 2
View Market Depth
Last trade - 14.49pm 24/06/2025 (20 minute delay) ?
ACR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.